Canada · Health Canada Drug Product Database
AMINOSYN II 8.5% INJECTION
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 18607
- DIN
- 00742627
- Form
- Solution
- Company as listed by source
- HOSPIRA HEALTHCARE ULC
- Source status
- Cancelled Post Market (2016-07-29)
- Source last updated
- 2025-03-22
Source-listed ingredients
- L-ISOLEUCINE — 561 MG — per 100 ML
- L-LEUCINE — 850 MG — per 100 ML
- L-LYSINE (L-LYSINE ACETATE) — 893 MG — per 100 ML
- METHIONINE — 146 MG — per 100 ML
- L-PHENYLALANINE — 253 MG — per 100 ML
- L-THREONINE — 340 MG — per 100 ML
- TRYPTOPHAN — 170 MG — per 100 ML
- L-VALINE — 425 MG — per 100 ML
- L-ALANINE — 844 MG — per 100 ML
- L-ARGININE — 865 MG — per 100 ML
- L-ASPARTIC ACID — 595 MG — per 100 ML
- GLUTAMIC ACID — 627 MG — per 100 ML
- GLYCINE — 425 MG — per 100 ML
- HISTIDINE — 255 MG — per 100 ML
- L-PROLINE — 614 MG — per 100 ML
- SERINE — 450 MG — per 100 ML
- N-ACETYL-L-TYROSINE — 230 MG — per 100 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 500ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →